These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro. Samuels LL, Moccio DM, Sirotnak FM. Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616 [Abstract] [Full Text] [Related]
8. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance. Sirotnak FM, Poser RE, Barrueco JR. Cancer Res; 1987 Oct 15; 47(20):5334-9. PubMed ID: 3498533 [Abstract] [Full Text] [Related]
9. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo. Poser RG, Sirotnak FM, Chello PL. Cancer Res; 1981 Nov 15; 41(11 Pt 1):4441-6. PubMed ID: 6171339 [Abstract] [Full Text] [Related]
10. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models. Sirotnak FM, Donsbach RC, Dorick DM, Moccio DM. Cancer Res; 1976 Dec 15; 36(12):4672-8. PubMed ID: 1000510 [Abstract] [Full Text] [Related]
12. Further evidence for a basis of selective activity and relative responsiveness during antifolate therapy of murine tumors. Sirotnak FM, Donsback RC. Cancer Res; 1975 Jul 15; 35(7):1737-44. PubMed ID: 1169115 [Abstract] [Full Text] [Related]
13. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate. Zhao R, Babani S, Gao F, Liu L, Goldman ID. Clin Cancer Res; 2000 Sep 15; 6(9):3687-95. PubMed ID: 10999762 [Abstract] [Full Text] [Related]
15. Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models. Sirotnak FM, Schmid FA, Otter GM, Piper JR, Montgomery JA. Cancer Res; 1988 Oct 15; 48(20):5686-91. PubMed ID: 3167828 [Abstract] [Full Text] [Related]
16. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system. Fry DW, Besserer JA, Boritzki TJ. Cancer Res; 1984 Aug 15; 44(8):3366-70. PubMed ID: 6547636 [Abstract] [Full Text] [Related]
18. Similar characteristics of folate analogue transport in vitro in contrast to varying dihydrofolate reductase levels in epithelial cells at different stages of maturation in mouse small intestine. Sirotnak FM, Moccio DM, Yang CH. Cancer Res; 1984 Nov 15; 44(11):5204-11. PubMed ID: 6488181 [Abstract] [Full Text] [Related]
19. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse. Samuels LL, Goutas LJ, Priest DG, Piper JR, Sirotnak FM. Cancer Res; 1986 May 15; 46(5):2230-5. PubMed ID: 2421872 [Abstract] [Full Text] [Related]
20. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Matherly LH, Czajkowski CA, Angeles SM. Cancer Res; 1991 Jul 01; 51(13):3420-6. PubMed ID: 2054782 [Abstract] [Full Text] [Related] Page: [Next] [New Search]